» Articles » PMID: 28096251

Healthcare Resource Consumption for Intermittent Urinary Catheterisation: Cost-effectiveness of Hydrophilic Catheters and Budget Impact Analyses

Overview
Journal BMJ Open
Specialty General Medicine
Date 2017 Jan 19
PMID 28096251
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study presents a cost-effectiveness analysis comparing hydrophilic coated to uncoated catheters for patients performing urinary intermittent catheterisation. A national budget impact analysis is also included to evaluate the impact of intermittent catheterisation for management of bladder dysfunctions over a period of 5 years.

Design: A Markov model (lifetime horizon, 1 year cycle length) was developed to project health outcomes (life years and quality-adjusted life years) and economic consequences related to patients using hydrophilic coated or uncoated catheters. The model was populated with catheter-related clinical efficacy data retrieved from randomised controlled trials and quality-of-life data (utility weights) from the literature. Cost data (EUR, 2015) were estimated on the basis of healthcare resource consumption derived from an e-survey addressed to key opinion leaders in the field.

Setting: Italian Healthcare Service perspective.

Population: Patients with spinal cord injury performing intermittent urinary catheterisation in the home setting.

Main Outcome Measures: Incremental cost-effectiveness and cost-utility ratios (ICER and ICUR) of hydrophilic coated versus uncoated catheters and associated healthcare budget impact.

Results: The base-case ICER and ICUR associated with hydrophilic coated catheters were €20 761 and €24 405, respectively. This implies that hydrophilic coated catheters are likely to be cost-effective in comparison to uncoated ones, as proposed Italian threshold values range between €25 000 and €66 400. Considering a market share at year 5 of 89% hydrophilic catheters and 11% uncoated catheters, the additional cost for Italy is approximately €12 million in the next 5 years (current market share scenario for year 0: 80% hydrophilic catheters and 20% uncoated catheters).

Conclusions: Considered over a lifetime, hydrophilic coated catheters are potentially a cost-effective choice in comparison to uncoated ones. These findings can assist policymakers in evaluating intermittent catheterisation in patients with spinal cord injury.

Citing Articles

Feasibility study on a new enhanced device for patients with intermittent catheterization (LUJA).

Calabro G, DAmbrosio F, Orsini F, Pappalardo C, Scardigno A, Rumi F J Prev Med Hyg. 2023; 64(3 Suppl 1):E1-E89.

PMID: 38125911 PMC: 10730013. DOI: 10.15167/2421-4248/jpmh2023.64.3s1.


A scoping review on the impact of hydrophilic versus non-hydrophilic intermittent catheters on UTI, QoL, satisfaction, preference, and other outcomes in neurogenic and non-neurogenic patients suffering from urinary retention.

Barken K, Vaabengaard R BMC Urol. 2022; 22(1):153.

PMID: 36123663 PMC: 9487088. DOI: 10.1186/s12894-022-01102-8.


Cost-effectiveness of hydrophilic-coated urinary catheters for individuals with spinal cord injury: A systematic review.

Xi M, Elterman D, Welk B, Pakosh M, Chan B BJUI Compass. 2022; 2(2):71-81.

PMID: 35474888 PMC: 8988762. DOI: 10.1002/bco2.63.


A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.

Chughtai B, Rojanasarot S, Neeser K, Gultyaev D, Fu S, Bhattacharyya S PLoS One. 2022; 17(4):e0266824.

PMID: 35427376 PMC: 9012364. DOI: 10.1371/journal.pone.0266824.


Intermittent catheter techniques, strategies and designs for managing long-term bladder conditions.

Prieto J, Murphy C, Stewart F, Fader M Cochrane Database Syst Rev. 2021; 10:CD006008.

PMID: 34699062 PMC: 8547544. DOI: 10.1002/14651858.CD006008.pub5.


References
1.
Cardenas D, Hoffman J . Hydrophilic catheters versus noncoated catheters for reducing the incidence of urinary tract infections: a randomized controlled trial. Arch Phys Med Rehabil. 2009; 90(10):1668-71. DOI: 10.1016/j.apmr.2009.04.010. View

2.
Lai K, Fontecchio S . Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002; 30(4):221-5. DOI: 10.1067/mic.2002.120128. View

3.
Cardenas D, Moore K, Dannels-McClure A, Scelza W, Graves D, Brooks M . Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PM R. 2011; 3(5):408-17. DOI: 10.1016/j.pmrj.2011.01.001. View

4.
Clark J, Mealing S, Scott D, Vogel L, Krassioukov A, Spinelli M . A cost-effectiveness analysis of long-term intermittent catheterisation with hydrophilic and uncoated catheters. Spinal Cord. 2015; 54(1):73-7. DOI: 10.1038/sc.2015.117. View

5.
Karchmer T, Giannetta E, Muto C, Strain B, Farr B . A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000; 160(21):3294-8. DOI: 10.1001/archinte.160.21.3294. View